| Product Code: ETC10186446 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Primary Progressive Multiple Sclerosis Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, 2021 & 2031F |
3.3 India Primary Progressive Multiple Sclerosis Market - Industry Life Cycle |
3.4 India Primary Progressive Multiple Sclerosis Market - Porter's Five Forces |
3.5 India Primary Progressive Multiple Sclerosis Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Primary Progressive Multiple Sclerosis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 India Primary Progressive Multiple Sclerosis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Primary Progressive Multiple Sclerosis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Primary Progressive Multiple Sclerosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about multiple sclerosis and its symptoms in India |
4.2.2 Growing research and development activities focused on finding effective treatments for primary progressive multiple sclerosis |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in India |
4.3 Market Restraints |
4.3.1 Limited access to advanced medical facilities and specialized healthcare professionals in certain regions of India |
4.3.2 High cost associated with the treatment and management of primary progressive multiple sclerosis |
4.3.3 Lack of standardized guidelines for the diagnosis and management of primary progressive multiple sclerosis in India |
5 India Primary Progressive Multiple Sclerosis Market Trends |
6 India Primary Progressive Multiple Sclerosis Market, By Types |
6.1 India Primary Progressive Multiple Sclerosis Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.4 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Immunosuppressants, 2021 - 2031F |
6.1.5 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Corticosteroids, 2021 - 2031F |
6.1.6 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 India Primary Progressive Multiple Sclerosis Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Disease-Modifying Therapy, 2021 - 2031F |
6.2.3 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Physical Therapy, 2021 - 2031F |
6.2.4 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Rehabilitation, 2021 - 2031F |
6.2.5 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 India Primary Progressive Multiple Sclerosis Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3.3 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.4 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Injection, 2021 - 2031F |
6.3.5 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 India Primary Progressive Multiple Sclerosis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.4 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.5 India Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Others, 2021 - 2031F |
7 India Primary Progressive Multiple Sclerosis Market Import-Export Trade Statistics |
7.1 India Primary Progressive Multiple Sclerosis Market Export to Major Countries |
7.2 India Primary Progressive Multiple Sclerosis Market Imports from Major Countries |
8 India Primary Progressive Multiple Sclerosis Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis of primary progressive multiple sclerosis |
8.2 Number of clinical trials conducted for primary progressive multiple sclerosis treatments in India |
8.3 Percentage of healthcare professionals trained in diagnosing and managing primary progressive multiple sclerosis |
8.4 Patient adherence rates to prescribed treatment plans |
8.5 Number of support groups or patient advocacy organizations focused on primary progressive multiple sclerosis in India |
9 India Primary Progressive Multiple Sclerosis Market - Opportunity Assessment |
9.1 India Primary Progressive Multiple Sclerosis Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Primary Progressive Multiple Sclerosis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 India Primary Progressive Multiple Sclerosis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Primary Progressive Multiple Sclerosis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Primary Progressive Multiple Sclerosis Market - Competitive Landscape |
10.1 India Primary Progressive Multiple Sclerosis Market Revenue Share, By Companies, 2024 |
10.2 India Primary Progressive Multiple Sclerosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here